Literature DB >> 17380399

Cryoglobulinemia related to hepatitis C virus infection.

Maria Pina Dore1, Giovanna Fattovich, Antonia R Sepulveda, Giuseppe Realdi.   

Abstract

A causal link among hepatitis C virus (HCV) infection and essential mixed cryoglobulinemia, cryoglobulinemic glomerulonephritis, and vasculitis is strongly supported. HCV triggers autoimmune response in predisposed individuals that manifests as organ-specific and non-organ-specific autoantibodies and as polyclonal/monoclonal rheumatoid factor, which has a central role in causing damaging cryoglobulin and immune complex tissue levels. Immunologic events are mainly induced by HCV infection persistence, with excessive immune stimulation. Humoral immune dysfunction leads to autoantibodies and rheumatoid factor production with cryoglobulinemia, glomerulonephritis, vasculitis, neuropathy, and probably thyroiditis, and arthritis in rare cases. Cellular immune dysfunction leads to lymphocytic infiltration, proliferation, and cytokine production. Pegylated (or not) interferon-alpha in combination with ribavirin appears to be the treatment of choice for patients with symptomatic essential mixed cryoglobulinemia with or without glomerulonephritis. Novel treatment with rituximab is promising.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380399     DOI: 10.1007/s10620-006-9510-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  90 in total

Review 1.  Renal involvement in essential mixed cryoglobulinemia.

Authors:  G D'Amico; G Colasanti; F Ferrario; R A Sinico
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

Review 2.  T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity.

Authors:  Yasunori Ichiki; Xiao-Song He; Shinji Shimoda; Hiromi Ishibashi; Emmet B Keeffe; Lorenzo Rossaro; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2005-01-12       Impact factor: 9.754

Review 3.  Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.

Authors:  M P Manns; E G Rambusch
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

4.  Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients.

Authors:  V Racanelli; D Sansonno; C Piccoli; F P D'Amore; F A Tucci; F Dammacco
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading.

Authors:  Xiaodong Feng; Marcia G Tonnesen; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

6.  PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

Authors:  Patrice Cacoub; David Saadoun; Nicolas Limal; Damien Sene; Olivier Lidove; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2005-03

7.  Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.

Authors:  R Misiani; P Bellavita; D Fenili; O Vicari; D Marchesi; P L Sironi; P Zilio; A Vernocchi; M Massazza; G Vendramin
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

8.  Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial.

Authors:  C Ferri; E Marzo; G Longombardo; F Lombardini; L La Civita; R Vanacore; A M Liberati; R Gerli; F Greco; A Moretti; M Monti; P Gentilini; S Bombardieri; A L Zignego
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

9.  Renal replacement therapy in cryoglobulinaemic nephritis.

Authors:  A Tarantino; G Moroni; G Banfi; C Manzoni; S Segagni; C Ponticelli
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

10.  Association of diabetes mellitus and chronic hepatitis C virus infection.

Authors:  A L Mason; J Y Lau; N Hoang; K Qian; G J Alexander; L Xu; L Guo; S Jacob; F G Regenstein; R Zimmerman; J E Everhart; C Wasserfall; N K Maclaren; R P Perrillo
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425

View more
  16 in total

1.  Is interleukin-8 an additional to histopathological changes diagnostic marker in HCV-infected patients with cryoglobulinemia?

Authors:  Joanna Cielecka-Kuszyk; Joanna Siennicka; Joanna Jabłońska; Olga Rek; Paulina Godzik; Daniel Rabczenko; Kazimierz Madaliński
Journal:  Hepatol Int       Date:  2011-03-20       Impact factor: 6.047

2.  Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.

Authors:  Poonam Mathur; Benjamin Emmanuel; Michael Sneller; Xiaozhen Zhang; Bhawna Poonia; Shyamasundaran Kottilil
Journal:  J Med Virol       Date:  2018-01-04       Impact factor: 2.327

3.  Effect of interferon treatment on hearing of patients with chronic hepatitis C.

Authors:  Abdulrahman Hagr; Dima Jamjoom; Faisal M Sanai; Waleed Al Hamoudi; Ayman A Abdo; Ahmed Al-Arfaj
Journal:  Saudi J Gastroenterol       Date:  2011 Mar-Apr       Impact factor: 2.485

4.  [Viral arthritis and vasculitis].

Authors:  U Sixdorf; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

5.  Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.

Authors:  B Emmanuel; N Sidique; X Zhang; B Poonia; M C Sneller; S Kottilil
Journal:  J Viral Hepat       Date:  2016-09-25       Impact factor: 3.728

6.  Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile.

Authors:  Martha Minopetrou; Emilia Hadziyannis; Melanie Deutsch; Maria Tampaki; Asimina Georgiadou; Eleni Dimopoulou; Dimitrios Vassilopoulos; John Koskinas
Journal:  Clin Vaccine Immunol       Date:  2013-03-06

7.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

8.  [Viral arthritides].

Authors:  E Märker-Hermann; N Schütz; H Bauer
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.530

Review 9.  Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.

Authors:  Takashi Himoto; Tsutomu Masaki
Journal:  Clin Dev Immunol       Date:  2012-09-05

Review 10.  Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations.

Authors:  Dimitrios Vassilopoulos; Leonard H Calabrese
Journal:  Arthritis Res Ther       Date:  2008-09-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.